Anti-Diabetic Effects of TongGuanWan, a Chinese Traditional Herbal Formula, in C57BL/KsJ-db/db Mice

Abstract

In the present study, the anti-diabetic effects of a traditional Chinese medicinal formula extract, TongGuanWan, were investigated in type 2 diabetic animals. It was orally administered to C57BL/KsJ-db/db mice once a day for 4 weeks at the doses of 62, 125, and 250 mg/kg body weight. TongGuanWan significantly lowered the blood glucose and glycosylated haemoglobin levels as well as improved the glucose tolerance in db/db mice. The serum triglyceride levels in the db/db mice were significantly decreased, whereas the high-density lipoprotein cholesterol levels were significantly increased, after treatment with this herbal formula. TongGuanWan also markedly decreased the animals' body weights compared to those of the control db/db group but did not alter food intake. The effects of TongGuanWan were compared to those of the drug rosiglitazone. In addition, five main constituents of TongGuanWan, mangiferin, berberine, cinnamic aldehyde, timosaponin BII, and timosaponin AIII, were quantified using high performance liquid chromatography coupled with a diode array and an evaporative light scattering detector (HPLC-DAD-ELSD). These results suggest that TongGuanWan may be useful for the treatment of type 2 diabetes.

Key words

TongGuanWan - herbal formula - type 2 diabetes - anti-diabetic effect

References

• 1 Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.  Diabetes Care. 2004;  27 1047-1053
• 2 Media Center/Diabetes. Available at http://www.who.int/mediacentre/factsheets/fs312/en/index.html Accessed August 1, 2008
• 3 Skyler J S. Diabetes mellitus: pathogenesis and treatment strategies.  J Med Chem. 2004;  47 4113-4117
• 4 Davis S N, Granner D K. Insulin, oral hypoglycemia agents and the pharmacology of the endocrine pancreas. In: Joel G H, Lee E, editors Goodman & Gilman's the pharmacological basis of therapeutics. New York: McGraw-Hill; 1996: 1679-1714
• 5 Jia W, Gao W, Ta L. Antidiabetic herbal drugs officially approved in China.  Phytother Res. 2003;  17 1127-1134
• 6 Kim J O, Lee G D, Kwon J H, Kim K S. Anti-diabetic effects of new herbal formula in neonatally streptozotocin-induced diabetic rats.  Biol Pharm Bull. 2009;  32 421-426
• 7 Miura T, Ichiki H, Iwamoto N, Kato M, Kubo M, Sasaki H, Okada M, Ishida T, Seino Y, Tanigawa K. Antidiabetic activity of the rhizoma of Anemarrhena asphodeloides and active components, mangiferin and its glucoside.  Biol Pharm Bull. 2001;  24 1009-1011
• 8 Kim H J, Kong M K, Kim Y C. Beneficial effects of Phellodendri Cortex extract on hyperglycemia and diabetic nephropathy in streptozotocin-induced diabetic rats.  BMB Rep. 2008;  41 710-715
• 9 Liu W H, Hei Z Q, Nie H, Tang F T, Huang H Q, Li X J, Deng Y H, Chen S R, Guo F F, Huang W G, Chen F Y, Liu P Q. Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase.  Chin Med J. 2008;  121 706-712
• 10 Kwon K B, Kim E K, Jeong E S, Lee Y H, Lee Y R, Park J W, Ryu D G, Park B H. Cortex Cinnamomi extract prevents streptozotocin- and cytokine-induced β-cell damage by inhibiting NF-κB.  World J Gastroenterol. 2006;  12 4331-4337
• 11 Chen H, Charlat O, Tartaglia L A, Woolf E A, Weng X, Ellis S J, Lakey N D, Culpepper J, Moore K J, Breitbart R E, Duyk G M, Tepper R I, Morgenstern J P. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice.  Cell. 1996;  84 491-495
• 12 Gerich J E. Clinical significance, pathogenesis, and management of postprandial hyperglycemia.  Arch Intern Med. 2003;  163 1306-1316
• 13 Yamanaka M, Itakura Y, Tsuchida A, Nakagawa T, Noguchi H, Taiji M. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.  Diabetes Obes Metab. 2007;  9 879-888
• 14 Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, Ide T, Kubota N, Terauchi Y, Tobe K, Miki H, Tsuchida A, Akanuma Y, Nagai R, Kimura S, Kadowaki T. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance.  J Biol Chem. 2001;  276 41245-41254
• 15 Bastard J P, Maachi M, Lagathu C, Kim M J, Caron M, Vidal H, Capeau J, Feve B. Recent advances in the relationship between obesity, inflammation, and insulin resistance.  Eur Cytokine Netw. 2006;  17 4-12
• 16 Villareal D T, Banks M R, Patterson B W, Polonsky K S, Klein S. Weight loss therapy improves pancreatic endocrine function in obese older adults.  Obesity (Silver Spring). 2008;  16 1349-1354
• 17 Ikeoka D, Krusinova E. Insulin resistance and lipid metabolism.  Rev Assoc Med Bras. 2009;  55 234
• 18 Chinese Pharmacopoeia. Part 1. Beijing: Beijing: China Medical Science and Technology Press; 2010: 127 197, 286
• 19 Sellamuthu P S, Muniappan B P, Perumal S M, Kandasamy M. Antihyperglycemic effect of mangiferin in streptozotocin induced diabetic rats.  J Health Sci. 2009;  55 206-214
• 20 Huang C G, Wang X L, Zhang Z Q, Shi S. Application of timosaponin A3 for preparing medicine for treating type 2 diabetes mellitus. CN Patent 02160151 2002
• 21 Awanish M, Rajbir B, Amarjit S, Mohan Paul S I. Ameliorative effect of the cinnamon oil from Cinnamomun zeylanicum upon early stage diabetic nephropathy.  Planta Med. 2010;  76 412-417